Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 August 2020 | Story Amanda Tongha | Photo NSFAS

Applications for the National Student Financial Aid Scheme (NSFAS) 2021 are now open.  

The NSFAS application cycle will run for a period of four months starting from 3 August to 30 November 2020. 

NSFAS applications are open to students from poor and working-class backgrounds who wish to further their studies at any public Technical and Vocational Education and Training (TVET) college or university. To qualify for NSFAS funding, the applicant must be a South African citizen; come from a family with a combined annual household income of not more than R350 000; for students with a disability, a combined annual household income of not more than R600 000. 

Applications for 2021 funding will be completed online via the myNSFAS portal as per previous years. 

New applicants need a copy of their ID or birth certificate to register and create a myNSFAS account or profile on the myNSFAS portal. Applicants with existing accounts must log on to their accounts to complete an application. Applicants are not allowed to create more than one profile on the portal. The applicant will be required to give consent to NSFAS to verify their personal information with third parties and will not be able to create a profile without giving this consent. This feature allows NSFAS to conduct a three-step verification process with the Department of Home Affairs (DHA), where an ID number will be linked to the name and surname of the applicant and the parents' details. 

In response to the status quo due to the COVID-19 pandemic, applicants will not be required to submit or upload the consent form; however, they will have to grant consent electronically during the application process, along with accepting the terms and conditions for funding. 

Applicants will, however, still be required to submit their supporting documents, comprising a copy of own ID; parents’/guardian's proof of income; copies of parents’/guardian's ID; and/or Annexure A for applicants with disabilities. 

Qualifying students are urged to make use of this opportunity and apply for funding in time. 

 
 

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept